![](/img/cover-not-exists.png)
Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)
Lamiae Grimaldi-Bensouda, Frederic Rouillon, Bernard Astruc, Michel Rossignol, Jacques Benichou, Bruno Falissard, Frederic Limosin, Beatrice Beaufils, Guillaume Vaiva, Helene Verdoux, Yola Moride, AlbVolume:
134
Year:
2012
Language:
english
DOI:
10.1016/j.schres.2011.10.022
File:
PDF, 291 KB
english, 2012